Does antiretroviral-induced hyperlipidaemia constitute a cardiovascular risk?

J HIV Ther. 2001 May;6(2):37-9.
No abstract available

Publication types

  • Review

MeSH terms

  • Antiretroviral Therapy, Highly Active / adverse effects*
  • Cardiovascular Diseases / epidemiology
  • Cardiovascular Diseases / etiology*
  • HIV Infections / drug therapy*
  • HIV Protease Inhibitors / adverse effects
  • Humans
  • Hyperlipidemias / chemically induced*
  • Hyperlipidemias / complications
  • Incidence
  • Reverse Transcriptase Inhibitors / adverse effects
  • Risk Factors
  • Treatment Failure

Substances

  • HIV Protease Inhibitors
  • Reverse Transcriptase Inhibitors